ACE2 and non-small cell lung carcinoma: To accurately study the association between ACE2 status and disease progression in NSCLC, 83 patients who had accepted radical excisions were dichotomized into either ACE2 low (≤1) or high (>1) expression group with a cut-off value, the median ACE2 score of excised tumors.